{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:00:04Z","timestamp":1785308404712,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061151"],"award-info":[{"award-number":["R01AG061151"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG055523"],"award-info":[{"award-number":["R01AG055523"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DH Chen Foundation","award":["R-86U55A"],"award-info":[{"award-number":["R-86U55A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Impaired axonal transport may contribute to the pathogenesis of neurodegenerative diseases, including Alzheimer\u2019s disease (AD) and Down syndrome (DS). Axonal transport is a complex process in which specific motor proteins move cargoes to and from neuronal cell bodies and their processes. Inconsistent reports point to the changes in AD in the levels of the classical anterograde motor protein kinesin family member 5 (KIF5) and the primary neuronal KIF regulator kinesin light chain 1 (KLC1), raising the possibility that anterograde transport is compromised in AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and materials<\/jats:title>\n                <jats:p>To address inconsistencies and determine if the shared pathologies in AD and elderly DS subjects with dementia (AD in DS; AD-DS) extend to the changes in KIF5 and KLC1, we measured the levels of all the three KIF5 family members and KLC1 in the AD and AD-DS frontal cortex and AD temporal cortex and cerebellum in samples taken with a short postmortem interval. To support future studies to explore the cell biological basis for any changes detected, we also examined the levels of these proteins in the brains of young and aged adult mice in the Dp (16)1Yey\/+ (Dp16) mouse model of DS and J20 mouse model of AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no changes in comparison with controls in KIF5 family members in either the AD or AD-DS samples when normalized to either \u03b2-actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Interestingly, however, samples from control brains as well as from AD and AD-DS demonstrated strong positive correlations between the levels of KIF5 family members, suggesting positive co-regulated expression. Importantly, while earlier reports pointed to a negative correlation between the levels of the amyloid precursor protein (APP) and KIF5A levels, we found the opposite to be true in AD-DS; this was especially striking given triplication of the APP gene, with increased APP protein levels. AD and control samples showed positive correlations between fl-hAPP and KIF5 members, but they were less consistent. In contrast to the findings for KIF5, the levels of KLC1 were downregulated in the frontal cortex of both AD and AD-DS brains; interestingly, this change was not seen in the AD temporal cortex or cerebellum. As postmortem interval has a negative effect on the levels of KLC1, but not KIF5 members, we analyzed a subset of samples with a very short postmortem interval (PMI) (\u2264 6\u2009h), a PMI that was not significantly correlated with the levels of KLC1 in either AD or AD-DS samples; we confirmed the presence of a statistically significant reduction of KLC1 in AD and AD-DS brains as compared with control brains. Studies comparing Dp16 to its euploid control recapitulated human studies in demonstrating no change in KIF5 levels and a positive correlation between the levels of KIF5 family members. J20 mice also showed normal KIF5 levels. However, unlike the AD and AD-DS frontal cortex, KLC1 levels were not reduced in the brains of Dp16 or J20 mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These data point to significant reductions in KLC1 in AD and AD-DS. In so doing, they raise the possibility of compromised KLC1-mediated axonal transport in these conditions, a posit that can now be pursued in model systems in which KLC1 expression is reduced.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00796-6","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:03:09Z","timestamp":1615356189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport"],"prefix":"10.1186","volume":"13","author":[{"given":"Xu-Qiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gooho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"796_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semcdb.2019.07.010","volume":"99","author":"W Guo","year":"2020","unstructured":"Guo W, Stoklund Dittlau K, Van Den Bosch L. Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin Cell Dev Biol. 2020;99:133\u201350.","journal-title":"Semin Cell Dev Biol"},{"issue":"12","key":"796_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41582-019-0257-2","volume":"15","author":"JN Sleigh","year":"2019","unstructured":"Sleigh JN, Rossor AM, Fellows AD, Tosolini AP, Schiavo G. Axonal transport and neurological disease. Nat Rev Neurol. 2019;15(12):691\u2013703.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"796_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrm2774","volume":"10","author":"N Hirokawa","year":"2009","unstructured":"Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10(10):682\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"796_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.neuron.2010.09.039","volume":"68","author":"N Hirokawa","year":"2010","unstructured":"Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 2010;68(4):610\u201338.","journal-title":"Neuron"},{"issue":"11","key":"796_CR5","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13(11):1396\u2013403.","journal-title":"Nat Neurosci"},{"issue":"7","key":"796_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET, Bagnato C, Han D, et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci. 2009;12(7):864\u201371.","journal-title":"Nat Neurosci"},{"issue":"14","key":"796_CR7","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1073\/pnas.0901229106","volume":"106","author":"G Pigino","year":"2009","unstructured":"Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, LaDu M, Busciglio J, Brady S. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci U S A. 2009;106(14):5907\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"796_CR8","doi-asserted-by":"crossref","unstructured":"Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimers Dement. 2021;17(2):271\u201392.","DOI":"10.1002\/alz.12185"},{"issue":"1","key":"796_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41467-018-03461-z","volume":"9","author":"Z Mo","year":"2018","unstructured":"Mo Z, Zhao X, Liu H, Hu Q, Chen XQ, Pham J, Wei N, Liu Z, Zhou J, Burgess RW, et al. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy. Nat Commun. 2018;9(1):1007.","journal-title":"Nat Commun"},{"issue":"38","key":"796_CR10","doi-asserted-by":"publisher","first-page":"E5655","DOI":"10.1073\/pnas.1603020113","volume":"113","author":"X Zhao","year":"2016","unstructured":"Zhao X, Chen XQ, Han E, Hu Y, Paik P, Ding Z, Overman J, Lau AL, Shahmoradian SH, Chiu W, et al. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington\u2019s disease. Proc Natl Acad Sci U S A. 2016;113(38):E5655\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"796_CR11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/JCI82409","volume":"126","author":"W Xu","year":"2016","unstructured":"Xu W, Weissmiller AM, White JA 2nd, Fang F, Wang X, Wu Y, Pearn ML, Zhao X, Sawa M, Chen S, et al. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Invest. 2016;126(5):1815\u201333.","journal-title":"J Clin Invest"},{"key":"796_CR12","doi-asserted-by":"crossref","unstructured":"Tammineni P, Ye X, Feng T, Aikal D, Cai Q. Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer\u2019s disease neurons. eLife. 2017;6:e21776.","DOI":"10.7554\/eLife.21776"},{"issue":"1","key":"796_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/acn3.147","volume":"2","author":"A Didonna","year":"2015","unstructured":"Didonna A, Opal P. The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol. 2015;2(1):79\u2013101.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1\u20132","key":"796_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000109998","volume":"29","author":"BL Plassman","year":"2007","unstructured":"Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1\u20132):125\u201332.","journal-title":"Neuroepidemiology"},{"issue":"10043","key":"796_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer\u2019s disease. Lancet. 2016;388(10043):505\u201317.","journal-title":"Lancet"},{"key":"796_CR16","doi-asserted-by":"crossref","unstructured":"Davis M, T OC, Johnson S, cline S, Merikle E, Martenyi F, Simpson K: Estimating Alzheimer\u2019s disease progression rates from normal cognition through mild cognitive impairment and stages of dementia. Curr Alzheimer Res 2018, 15(8):777\u2013788.","DOI":"10.2174\/1567205015666180119092427"},{"key":"796_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC. Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric Abeta and tau species. Front Neurosci. 2019;13:659.","journal-title":"Front Neurosci"},{"issue":"6","key":"796_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","volume":"15","author":"C Ballard","year":"2016","unstructured":"Ballard C, Mobley W, Hardy J, Williams G, Corbett A. Dementia in Down\u2019s syndrome. The Lancet Neurol. 2016;15(6):622\u201336.","journal-title":"The Lancet Neurol"},{"issue":"9","key":"796_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","volume":"16","author":"FK Wiseman","year":"2015","unstructured":"Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev. 2015;16(9):564\u201374.","journal-title":"Nat Rev"},{"issue":"9","key":"796_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/GIM.0b013e3181b2e34c","volume":"11","author":"A Megarbane","year":"2009","unstructured":"Megarbane A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethore MO, Delabar JM, Mobley WC. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med. 2009;11(9):611\u20136.","journal-title":"Genet Med"},{"issue":"29","key":"796_CR21","doi-asserted-by":"publisher","first-page":"12031","DOI":"10.1073\/pnas.0813248106","volume":"106","author":"JO Korbel","year":"2009","unstructured":"Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A. 2009;106(29):12031\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"796_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW, Potkin SG, Lott IT. Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. J Alzheimers Dis. 2017;56(2):459\u201370.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"796_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC. Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome. Ann Neurol. 1998;43(3):380\u20133.","journal-title":"Ann Neurol"},{"issue":"3","key":"796_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62(3):1403\u201316.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"796_CR25","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1083\/jcb.201612148","volume":"216","author":"S Gowrishankar","year":"2017","unstructured":"Gowrishankar S, Wu Y, Ferguson SM. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology. J Cell Biol. 2017;216(10):3291\u2013305.","journal-title":"J Cell Biol"},{"key":"796_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fnins.2019.00446","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC. Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses. Front Neurosci. 2019;13:446.","journal-title":"Front Neurosci"},{"key":"796_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2017.10.341","volume":"114","author":"XQ Chen","year":"2018","unstructured":"Chen XQ, Sawa M, Mobley WC. Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. Free Radic Biol Med. 2018;114:52\u201361.","journal-title":"Free Radic Biol Med"},{"issue":"6864","key":"796_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/414643a","volume":"414","author":"A Kamal","year":"2001","unstructured":"Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 2001;414(6864):643\u20138.","journal-title":"Nature"},{"issue":"7","key":"796_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0092-8674(00)81459-2","volume":"93","author":"Y Tanaka","year":"1998","unstructured":"Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, Hirokawa N. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell. 1998;93(7):1147\u201358.","journal-title":"Cell"},{"issue":"6","key":"796_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.devcel.2008.04.003","volume":"14","author":"JB Dictenberg","year":"2008","unstructured":"Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell. 2008;14(6):926\u201339.","journal-title":"Dev Cell"},{"issue":"15","key":"796_CR31","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/emboj.2008.133","volume":"27","author":"E Colin","year":"2008","unstructured":"Colin E, Zala D, Liot G, Rangone H, Borrell-Pages M, Li XJ, Saudou F, Humbert S. Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons. EMBO J. 2008;27(15):2124\u201334.","journal-title":"EMBO J"},{"issue":"17","key":"796_CR32","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1523\/JNEUROSCI.20-17-06374.2000","volume":"20","author":"Y Kanai","year":"2000","unstructured":"Kanai Y, Okada Y, Tanaka Y, Harada A, Terada S, Hirokawa N. KIF5C, a novel neuronal kinesin enriched in motor neurons. J Neurosci. 2000;20(17):6374\u201384.","journal-title":"J Neurosci"},{"issue":"6","key":"796_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1083\/jcb.146.6.1277","volume":"146","author":"A Rahman","year":"1999","unstructured":"Rahman A, Kamal A, Roberts EA, Goldstein LS. Defective kinesin heavy chain behavior in mouse kinesin light chain mutants. J Cell Biol. 1999;146(6):1277\u201388.","journal-title":"J Cell Biol"},{"key":"796_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer\u2019s disease. Mol Brain. 2011;4:3.","journal-title":"Mol Brain"},{"issue":"1","key":"796_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nn.4188","volume":"19","author":"U Das","year":"2016","unstructured":"Das U, Wang L, Ganguly A, Saikia JM, Wagner SL, Koo EH, Roy S. Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci. 2016;19(1):55\u201364.","journal-title":"Nat Neurosci"},{"issue":"2","key":"796_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1091\/mbc.E14-06-1049","volume":"26","author":"ED Niederst","year":"2015","unstructured":"Niederst ED, Reyna SM, Goldstein LS. Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing. Mol Biol Cell. 2015;26(2):205\u201317.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"796_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","volume":"51","author":"A Salehi","year":"2006","unstructured":"Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, et al. Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006;51(1):29\u201342.","journal-title":"Neuron"},{"issue":"21","key":"796_CR38","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1093\/hmg\/dds297","volume":"21","author":"EM Rodrigues","year":"2012","unstructured":"Rodrigues EM, Weissmiller AM, Goldstein LS. Enhanced beta-secretase processing alters APP axonal transport and leads to axonal defects. Hum Mol Genet. 2012;21(21):4587\u2013601.","journal-title":"Hum Mol Genet"},{"issue":"27","key":"796_CR39","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1523\/JNEUROSCI.1074-10.2010","volume":"30","author":"H Decker","year":"2010","unstructured":"Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci. 2010;30(27):9166\u201371.","journal-title":"J Neurosci"},{"issue":"4","key":"796_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","volume":"1812","author":"MJ Calkins","year":"2011","unstructured":"Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer\u2019s disease neurons. Biochim Biophys Acta. 2011;1812(4):507\u201313.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"796_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/mp.2015.97","volume":"21","author":"S Kim","year":"2016","unstructured":"Kim S, Sato Y, Mohan PS, Peterhoff C, Pensalfini A, Rigoglioso A, Jiang Y, Nixon RA. Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer\u2019s disease. Mol Psychiatry. 2016;21(5):707\u201316.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"796_CR42","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3233\/JAD-170094","volume":"60","author":"K Hares","year":"2017","unstructured":"Hares K, Miners JS, Cook AJ, Rice C, Scolding N, Love S, Wilkins A. Overexpression of Kinesin superfamily motor proteins in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60(4):1511\u201324.","journal-title":"J Alzheimers Dis"},{"key":"796_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.nbd.2019.03.021","volume":"127","author":"Q Wang","year":"2019","unstructured":"Wang Q, Tian J, Chen H, Du H, Guo L. Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement. Neurobiol Dis. 2019;127:410\u20138.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"796_CR44","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI66407","volume":"124","author":"D Sepulveda-Falla","year":"2014","unstructured":"Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, Korwitz A, Vinueza-Veloz MF, Zhou K, Schonewille M, Zhou H, Velazquez-Perez L, Rodriguez-Labrada R, et al. Familial Alzheimer\u2019s disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J Clin Invest. 2014;124(4):1552\u201367.","journal-title":"J Clin Invest"},{"issue":"1","key":"796_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40478-019-0857-5","volume":"7","author":"GM Morotz","year":"2019","unstructured":"Morotz GM, Glennon EB, Greig J, Lau DHW, Bhembre N, Mattedi F, Muschalik N, Noble W, Vagnoni A, Miller CCJ. Kinesin light chain-1 serine-460 phosphorylation is altered in Alzheimer\u2019s disease and regulates axonal transport and processing of the amyloid precursor protein. Acta Neuropathol Commun. 2019;7(1):200.","journal-title":"Acta Neuropathol Commun"},{"issue":"37","key":"796_CR46","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1523\/JNEUROSCI.1899-16.2016","volume":"36","author":"MA Sherman","year":"2016","unstructured":"Sherman MA, LaCroix M, Amar F, Larson ME, Forster C, Aguzzi A, Bennett DA, Ramsden M, Lesne SE. Soluble conformers of Abeta and tau alter selective proteins governing axonal transport. J Neurosci. 2016;36(37):9647\u201358.","journal-title":"J Neurosci"},{"issue":"1","key":"796_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-011-0901-4","volume":"123","author":"M Morel","year":"2012","unstructured":"Morel M, Heraud C, Nicaise C, Suain V, Brion JP. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer\u2019s disease: implications for axoplasmic transport. Acta Neuropathol. 2012;123(1):71\u201384.","journal-title":"Acta Neuropathol"},{"key":"796_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/amrcopenres.12861.1","volume":"1","author":"K Hares","year":"2019","unstructured":"Hares K, Miners S, Scolding N, Love S, Wilkins A. KIF5A and KLC1 expression in Alzheimer\u2019s disease: relationship and genetic influences [version 2; peer review: 2 approved, 1 approved with reservations]. AMRC Open Res. 2019;1:1 https:\/\/doi.org\/10.12688\/amrcopenres.12861.12682.","journal-title":"AMRC Open Res"},{"issue":"14","key":"796_CR49","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","volume":"19","author":"T Yu","year":"2010","unstructured":"Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N, et al. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet. 2010;19(14):2780\u201391.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"796_CR50","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1523\/JNEUROSCI.2513-15.2016","volume":"36","author":"JW Goodliffe","year":"2016","unstructured":"Goodliffe JW, Olmos-Serrano JL, Aziz NM, Pennings JL, Guedj F, Bianchi DW, Haydar TF. Absence of prenatal forebrain defects in the Dp (16)1Yey\/+ mouse model of Down syndrome. J Neurosci. 2016;36(10):2926\u201344.","journal-title":"J Neurosci"},{"key":"796_CR51","first-page":"103","volume":"9","author":"KJ Gardiner","year":"2015","unstructured":"Gardiner KJ. Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. Drug Des Dev Ther. 2015;9:103\u201325.","journal-title":"Drug Des Dev Ther"},{"key":"796_CR52","doi-asserted-by":"crossref","unstructured":"Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW et al: \u03b2-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995, 81(4):525\u2013531.","DOI":"10.1016\/0092-8674(95)90073-X"},{"issue":"2","key":"796_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jmcb\/mju011","volume":"6","author":"XQ Chen","year":"2014","unstructured":"Chen XQ, Zhu JX, Wang Y, Zhang X, Bao L. CaMKIIalpha and caveolin-1 cooperate to drive ATP-induced membrane delivery of the P2X3 receptor. J Mol Cell Biol. 2014;6(2):140\u201353.","journal-title":"J Mol Cell Biol"},{"issue":"Database issue","key":"796_CR54","doi-asserted-by":"publisher","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38(Database issue):D792\u20139.","journal-title":"Nucleic Acids Res"},{"key":"796_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-12-804766-8.00017-0","volume":"167","author":"MS Rafii","year":"2019","unstructured":"Rafii MS, Kleschevnikov AM, Sawa M, Mobley WC. Down syndrome. Handb Clin Neurol. 2019;167:321\u201336.","journal-title":"Handb Clin Neurol"},{"issue":"Pt 3","key":"796_CR56","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/brain\/awt372","volume":"137","author":"MF Iulita","year":"2014","unstructured":"Iulita MF, Do Carmo S, Ower AK, Fortress AM, Flores Aguilar L, Hanna M, Wisniewski T, Granholm AC, Buhusi M, Busciglio J, et al. Nerve growth factor metabolic dysfunction in Down\u2019s syndrome brains. Brain. 2014;137(Pt 3):860\u201372.","journal-title":"Brain"},{"issue":"7","key":"796_CR57","doi-asserted-by":"publisher","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","volume":"1","author":"A Salehi","year":"2009","unstructured":"Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, et al. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med. 2009;1(7):7ra17.","journal-title":"Sci Transl Med"},{"key":"796_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","volume":"1366","author":"T Yu","year":"2010","unstructured":"Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R, et al. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res. 2010;1366:162\u201371.","journal-title":"Brain Res"},{"issue":"11","key":"796_CR59","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20(11):4050\u20138.","journal-title":"J Neurosci"},{"issue":"52","key":"796_CR60","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1523\/JNEUROSCI.4180-06.2006","volume":"26","author":"MJ Saganich","year":"2006","unstructured":"Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci. 2006;26(52):13428\u201336.","journal-title":"J Neurosci"},{"issue":"4","key":"796_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059586","volume":"8","author":"AL Wright","year":"2013","unstructured":"Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A, Vissel B. Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer\u2019s disease. PLoS One. 2013;8(4):e59586.","journal-title":"PLoS One"},{"issue":"6286","key":"796_CR62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (New York, NY). 2016;352(6286):712\u20136.","journal-title":"Science (New York, NY)"},{"issue":"Pt 11","key":"796_CR63","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1242\/jcs.113.11.2047","volume":"113","author":"FK Gyoeva","year":"2000","unstructured":"Gyoeva FK, Bybikova EM, Minin AA. An isoform of kinesin light chain specific for the Golgi complex. J Cell Sci. 2000;113(Pt 11):2047\u201354.","journal-title":"J Cell Sci"},{"issue":"3","key":"796_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev. 2013;14(3):161\u201376.","journal-title":"Nat Rev"},{"key":"796_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","volume":"31","author":"KJ De Vos","year":"2008","unstructured":"De Vos KJ, Grierson AJ, Ackerley S, Miller CC. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci. 2008;31:151\u201373.","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"796_CR66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/1352458513508836","volume":"20","author":"K Hares","year":"2014","unstructured":"Hares K, Kemp K, Rice C, Gray E, Scolding N, Wilkins A. Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis. Mult Scler. 2014;20(7):812\u201321.","journal-title":"Mult Scler"},{"issue":"3","key":"796_CR67","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/nan.12305","volume":"43","author":"K Hares","year":"2017","unstructured":"Hares K, Redondo J, Kemp K, Rice C, Scolding N, Wilkins A. Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter. Neuropathol Appl Neurobiol. 2017;43(3):227\u201341.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"796_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-014-0144-4","volume":"2","author":"KL Kreft","year":"2014","unstructured":"Kreft KL, van Meurs M, Wierenga-Wolf AF, Melief MJ, van Strien ME, Hol EM, Oostra BA, Laman JD, Hintzen RQ. Abundant kif21b is associated with accelerated progression in neurodegenerative diseases. Acta Neuropathol Commun. 2014;2:144.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"796_CR69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gene.2010.30","volume":"11","author":"A Alcina","year":"2010","unstructured":"Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O, Cavanillas ML, Cenit MC, Arroyo R, Alloza I, et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun. 2010;11(5):439\u201345.","journal-title":"Genes Immun"},{"issue":"22","key":"796_CR70","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.0000000000011064","volume":"95","author":"S Saez-Atienzar","year":"2020","unstructured":"Saez-Atienzar S, Dalgard CL, Ding J, Chio A, Alba C, Hupalo DN, Wilkerson MD, Bowser R, Pioro EP, Bedlack R, et al. Identification of a pathogenic intronic KIF5A mutation in an ALS-FTD kindred. Neurology. 2020;95(22):1015\u20138.","journal-title":"Neurology"},{"issue":"2","key":"796_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1399-0004.2011.01717.x","volume":"82","author":"C Crimella","year":"2012","unstructured":"Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, Martinuzzi A, Trabacca A, Losito L, Scarlato M, et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet. 2012;82(2):157\u201364.","journal-title":"Clin Genet"},{"issue":"6","key":"796_CR72","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.neuron.2018.02.027","volume":"97","author":"A Nicolas","year":"2018","unstructured":"Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268\u201383 e1266.","journal-title":"Neuron"},{"issue":"5","key":"796_CR73","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1086\/344210","volume":"71","author":"E Reid","year":"2002","unstructured":"Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002;71(5):1189\u201394.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"796_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.025","volume":"1123","author":"AD Stan","year":"2006","unstructured":"Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA. Human postmortem tissue: what quality markers matter? Brain Res. 2006;1123(1):1\u201311.","journal-title":"Brain Res"},{"issue":"4","key":"796_CR75","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0167-7152(99)00030-9","volume":"44","author":"JH Kim","year":"1999","unstructured":"Kim JH. Spurious correlation between ratios with a common divisor. Stat Probabil Lett. 1999;44(4):383\u20136.","journal-title":"Stat Probabil Lett"},{"key":"796_CR76","doi-asserted-by":"crossref","unstructured":"Zhao J, Fok AHK, Fan R, Kwan PY, Chan HL, Lo LH, Chan YS, Yung WH, Huang J, Lai CSW, et al. Specific depletion of the motor protein KIF5B leads to deficits in dendritic transport, synaptic plasticity and memory. eLife. 2020;9:e53456.","DOI":"10.7554\/eLife.53456"},{"issue":"2","key":"796_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10048-012-0324-y","volume":"13","author":"KN Karle","year":"2012","unstructured":"Karle KN, Mockel D, Reid E, Schols L. Axonal transport deficit in a KIF5A( -\/- ) mouse model. Neurogenetics. 2012;13(2):169\u201379.","journal-title":"Neurogenetics"},{"issue":"2","key":"796_CR78","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0896-6273(00)00124-0","volume":"28","author":"A Kamal","year":"2000","unstructured":"Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 2000;28(2):449\u201359.","journal-title":"Neuron"},{"issue":"18","key":"796_CR79","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1523\/JNEUROSCI.0780-09.2009","volume":"29","author":"TL Falzone","year":"2009","unstructured":"Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, Williams DS, Goldstein LS. Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J Neurosci. 2009;29(18):5758\u201367.","journal-title":"J Neurosci"},{"issue":"5","key":"796_CR80","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1083\/jcb.152.5.959","volume":"152","author":"KJ Verhey","year":"2001","unstructured":"Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, Rapoport TA, Margolis B. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol. 2001;152(5):959\u201370.","journal-title":"J Cell Biol"},{"issue":"8","key":"796_CR81","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1242\/bio.20121578","volume":"1","author":"M Steuble","year":"2012","unstructured":"Steuble M, Diep TM, Schatzle P, Ludwig A, Tagaya M, Kunz B, Sonderegger P. Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport. Biol Open. 2012;1(8):761\u201374.","journal-title":"Biol Open"},{"issue":"13","key":"796_CR82","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/hmg\/dds109","volume":"21","author":"A Vagnoni","year":"2012","unstructured":"Vagnoni A, Perkinton MS, Gray EH, Francis PT, Noble W, Miller CC. Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Abeta production. Hum Mol Genet. 2012;21(13):2845\u201354.","journal-title":"Hum Mol Genet"},{"key":"796_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fncel.2016.00057","volume":"10","author":"A Padzik","year":"2016","unstructured":"Padzik A, Deshpande P, Hollos P, Franker M, Rannikko EH, Cai D, Prus P, Magard M, Westerlund N, Verhey KJ, et al. KIF5C S176 phosphorylation regulates microtubule binding and transport efficiency in mammalian neurons. Front Cell Neurosci. 2016;10:57.","journal-title":"Front Cell Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00796-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T23:03:22Z","timestamp":1675033402000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00796-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00796-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures related to human samples were carried out under a protocol reviewed and approved by the human subjects review board at UCSD (IRB #: 180620). All the animal studies were performed strictly according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experiments involving the use of animals have been approved by the University of California San Diego Institutional Animal Care and Use Committee (Protocol #: S09315, S02216M).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}